Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Illegal veterinary medicines a ‘significant and growing problem’
Illegal veterinary medicines comprise of counterfeit, falsified and unregistered products.
Report identifies risks to animals and humans 

Illegal veterinary medicines are costing the global animal health industry an estimated $1-2 billion per year, according to a report by the global medicines association, HealthforAnimals.

The report, Illegal Veterinary Medicines: Impacts and Effective Control, is the first ever assessment of illegal veterinary medicines. It outlines the size of the illegal veterinary medicines market and identifies some of the major risks to animals, vets, people and business.

“For the Animal Health industry as a whole, illegal veterinary medicines are a significant and growing problem,” the report notes. “The continuing rapid growth in online buying and selling of products (e-commerce) and a parallel growth in international trade especially of small packages, has created new opportunities for trade in illegal veterinary medicines.”

Illegal veterinary medicines comprise of counterfeit, falsified and unregistered products and unapproved parallel imports. They also include compounded pharmaceuticals and illegal autogenous vaccines when these products are not manufactured according to regulation.

Risks identified by the report include damage to business reputation arising from safety issues and the associated loss of confidence in authentic medicines. It also notes a risk to human safety through the consumption of food from animals treated with illegal medicines, less effective control of zoonotic infections and risks of increasing antimicrobial and antiparasitic resistance.

The report makes a number of recommendations to develop an effective strategy for the control of illegal veterinary medicines. They include communicating an effective narrative with an emphasis on safety, collaborating with enforcement agencies, and using data to show trends and case studies.

HealthforAnimals says that it may take up to seven years and appropriate resources for the recommendations to come into effect and to see the full impact on illegal veterinary medicines.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.